Terms: = Lymphoma AND EZR, CVIL, 7430, ENSG00000092820, P15311, MGC1584, FLJ26216, DKFZp762H157, CVL
23 results:
1. Frequency and functional characterization of fusion genes in squamous cell carcinoma of the lung.
Alidousty C; Becker A; Binot E; Hillmer AM; Merkelbach-Bruse S; Budde B; Bäßmann I; Rappl G; Wolf J; Eich ML; Noh KW; Buettner R; Schultheis AM
Gene; 2024 Feb; 895():148018. PubMed ID: 37981082
[TBL] [Abstract] [Full Text] [Related]
2. Detection of clinically actionable gene fusions by next-generation sequencing-based RNA sequencing of non-small cell lung cancer cytology specimens: A single-center experience with comparison to fluorescence in situ hybridization.
Diks J; Tang Z; Altan M; Anderson S; Chen H; Rashid A; Yang RK; Routbort MJ; Patel KP; Toruner GA; Medeiros LJ; Tang G; Luthra R; Roy-Chowdhuri S
Cancer Cytopathol; 2024 Jan; 132(1):41-49. PubMed ID: 37747438
[TBL] [Abstract] [Full Text] [Related]
3. Timing of Central Venous Line Insertion During Induction in Children With Acute Lymphoblastic Leukemia.
Ataseven E; Yilmaz Ş; Tüfekçi Ö; Ören H
J Pediatr Hematol Oncol; 2023 Jan; 45(1):25-28. PubMed ID: 36598960
[TBL] [Abstract] [Full Text] [Related]
4. ezrin is highly expressed and a druggable target in chronic lymphocytic leukemia.
Lipreri da Silva JC; Saldanha-Araujo F; de Melo RCB; Vicari HP; Silva-Carvalho AE; Rego EM; Buccheri V; Machado-Neto JA
Life Sci; 2022 Dec; 311(Pt B):121146. PubMed ID: 36336127
[TBL] [Abstract] [Full Text] [Related]
5. Potential Unreliability of Uncommon ALK, ROS1, and RET Genomic Breakpoints in Predicting the Efficacy of Targeted Therapy in NSCLC.
Li W; Guo L; Liu Y; Dong L; Yang L; Chen L; Liu K; Shao Y; Ying J
J Thorac Oncol; 2021 Mar; 16(3):404-418. PubMed ID: 33248323
[TBL] [Abstract] [Full Text] [Related]
6. Risk Factors for Cancer-specific Mortality and Cardiovascular Mortality in Patients With Diffuse Large B-cell lymphoma.
Zhao J; Su L; Zhong J
Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e858-e863. PubMed ID: 32680777
[TBL] [Abstract] [Full Text] [Related]
7. Different Types of
He Y; Sheng W; Hu W; Lin J; Liu J; Yu B; Mao X; Zhang L; Huang J; Wang G
Oncol Res; 2019 Aug; 27(8):901-910. PubMed ID: 30940295
[No Abstract] [Full Text] [Related]
8. Feasibility and safety of delivering full-dose anticoagulation therapy in children treated according to Dana-Farber Cancer Institute acute lymphoblastic leukemia consortium therapy protocols.
Bhatt MD; Parmar N; Fowler JA; Chan AKC; Athale UH
Pediatr Blood Cancer; 2019 Feb; 66(2):e27483. PubMed ID: 30362248
[TBL] [Abstract] [Full Text] [Related]
9. Thrombosis in pediatric patients with leukemia.
Levy-Mendelovich S; Barg AA; Kenet G
Thromb Res; 2018 Apr; 164 Suppl 1():S94-S97. PubMed ID: 29703491
[TBL] [Abstract] [Full Text] [Related]
10. Targeted next-generation-sequencing for reliable detection of targetable rearrangements in lung adenocarcinoma-a single center retrospective study.
Velizheva NP; Rechsteiner MP; Valtcheva N; Freiberger SN; Wong CE; Vrugt B; Zhong Q; Wagner U; Moch H; Hillinger S; Schmitt-Opitz I; Soltermann A; Wild PJ; Tischler V
Pathol Res Pract; 2018 Apr; 214(4):572-578. PubMed ID: 29580750
[TBL] [Abstract] [Full Text] [Related]
11. A minor role of asparaginase in predisposing to cerebral venous thromboses in adult acute lymphoblastic leukemia patients.
Roininen S; Laine O; Kauppila M; Vesanen M; Rämet M; Sinisalo M; Jantunen E; Säily M; Räty R; Elonen E; Wartiovaara-Kautto U
Cancer Med; 2017 Jun; 6(6):1275-1285. PubMed ID: 28503810
[TBL] [Abstract] [Full Text] [Related]
12. Custom Gene Capture and Next-Generation Sequencing to Resolve Discordant ALK Status by FISH and IHC in Lung Adenocarcinoma.
Jang JS; Wang X; Vedell PT; Wen J; Zhang J; Ellison DW; Evans JM; Johnson SH; Yang P; Sukov WR; Oliveira AM; Vasmatzis G; Sun Z; Jen J; Yi ES
J Thorac Oncol; 2016 Nov; 11(11):1891-1900. PubMed ID: 27343444
[TBL] [Abstract] [Full Text] [Related]
13. Crizotinib-Resistant ROS1 Mutations Reveal a Predictive Kinase Inhibitor Sensitivity Model for ROS1- and ALK-Rearranged Lung Cancers.
Facchinetti F; Loriot Y; Kuo MS; Mahjoubi L; Lacroix L; Planchard D; Besse B; Farace F; Auger N; Remon J; Scoazec JY; André F; Soria JC; Friboulet L
Clin Cancer Res; 2016 Dec; 22(24):5983-5991. PubMed ID: 27401242
[TBL] [Abstract] [Full Text] [Related]
14. Epidemiology of venous thrombosis in children with cancer.
Piovesan D; Attard C; Monagle P; Ignjatovic V
Thromb Haemost; 2014 Jun; 111(6):1015-21. PubMed ID: 24522152
[TBL] [Abstract] [Full Text] [Related]
15. ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases.
Yoshida A; Kohno T; Tsuta K; Wakai S; Arai Y; Shimada Y; Asamura H; Furuta K; Shibata T; Tsuda H
Am J Surg Pathol; 2013 Apr; 37(4):554-62. PubMed ID: 23426121
[TBL] [Abstract] [Full Text] [Related]
16. Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes.
Del Giudice I; Messina M; Chiaretti S; Santangelo S; Tavolaro S; De Propris MS; Nanni M; Pescarmona E; Mancini F; Pulsoni A; Martelli M; Di Rocco A; Finolezzi E; Paoloni F; Mauro FR; Cuneo A; Guarini A; Foà R
Br J Haematol; 2012 Mar; 156(5):601-11. PubMed ID: 22150124
[TBL] [Abstract] [Full Text] [Related]
17. Cranial vault lymphoma: a systematic review of five patients.
da Rocha AJ; da Rocha TM; da Silva CJ; Paes RP; Bruniera P; Chiattone CS
J Neurooncol; 2010 Oct; 100(1):9-15. PubMed ID: 20146083
[TBL] [Abstract] [Full Text] [Related]
18. Epidemiology and clinical risk factors predisposing to thromboembolism in children with cancer.
Athale U; Siciliano S; Thabane L; Pai N; Cox S; Lathia A; Khan A; Armstrong A; Chan AK
Pediatr Blood Cancer; 2008 Dec; 51(6):792-7. PubMed ID: 18798556
[TBL] [Abstract] [Full Text] [Related]
19. Thromboembolic complications in pediatric hematologic malignancies.
Athale UH; Chan AK
Semin Thromb Hemost; 2007 Jun; 33(4):416-26. PubMed ID: 17525899
[TBL] [Abstract] [Full Text] [Related]
20. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement.
McLean TW; Fisher CJ; Snively BM; Chauvenet AR
J Clin Oncol; 2005 May; 23(13):3024-9. PubMed ID: 15860859
[TBL] [Abstract] [Full Text] [Related]
[Next]
